Literature DB >> 8067782

Rapid identification of metallo- and serine beta-lactamases.

D J Payne1, R Cramp, J H Bateson, J Neale, D Knowles.   

Abstract

Simple methods to detect, identify, and differentiate metallo- and serine beta-lactamases were developed and used to differentiate enzymes produced by 17 clinical isolates of Xanthomonas maltophilia. All isolates exhibited beta-lactamase activity, and in 16 strains this was induced by imipenem. All but one isolate hydrolyzed imipenem (and meropenem), and in all cases this activity was inhibited by 1 mM EDTA. The metallo- and serine beta-lactamases in the cell extracts were distinguished on isoelectric focusing (IEF) gels by using the following procedures. (i) Cell lysates were preincubated with 83 mM EDTA prior to IEF and subsequent visualization with nitrocefin, and (ii) after IEF, the gels were overlaid with either 1 mM zinc sulfate or 100 microM BRL 42715 before staining with nitrocefin. Bands of beta-lactamase activity which were removed by BRL 42715 but unaffected by EDTA or zinc sulfate were categorized as serine beta-lactamases. Bands which were unaffected by BRL 42715 but inhibited by EDTA or enhanced by zinc sulfate were classified as metallo-beta-lactamases. By using this approach, seven metallo-beta-lactamases were differentiated with pI values of 4.8 (two strains), 5.5 (four strains), 5.7 (one strain), 6.0 (one strain), 6.4 (four strains), 6.6 (one strain), and 6.8 (three strains). The metallo-beta-lactamase band with a pI of 6.4 aligned with the recently characterized metallo-beta-lactamase from X. maltophilia 511. Heterogeneity was also observed for the serine beta-lactamases: 14 isolates elaborated serine beta-lactamase activity which focused with major bands with at least eight different pIs. The remaining three strains produced serine beta-lactamases which focused with five distinct bands with pIs of 6.4, 6.2, 5.7, 5.5, and 5.2. We conclude that X. maltophilia produces many types of metallo- and serine beta-lactamases distinguishable by these new methods and that the previously reported L-1 and L-2 enzymes are not solely representative of the beta-lactamases produced by this species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067782      PMCID: PMC188139          DOI: 10.1128/AAC.38.5.991

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  The automated in-vitro assessment of beta-lactamase inhibitors.

Authors:  D J Payne; K Coleman; R Cramp
Journal:  J Antimicrob Chemother       Date:  1991-11       Impact factor: 5.790

2.  Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors.

Authors:  L S Elting; N Khardori; G P Bodey; V Fainstein
Journal:  Infect Control Hosp Epidemiol       Date:  1990-03       Impact factor: 3.254

3.  Characterization of beta-lactamases in situ on polyacrylamide gels.

Authors:  C C Sanders; W E Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

4.  The production and molecular properties of the zinc beta-lactamase of Pseudomonas maltophilia IID 1275.

Authors:  R Bicknell; E L Emanuel; J Gagnon; S G Waley
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

5.  In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.

Authors:  K Coleman; D R Griffin; J W Page; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 6.  Metallo-beta-lactamases--a new therapeutic challenge.

Authors:  D J Payne
Journal:  J Med Microbiol       Date:  1993-08       Impact factor: 2.472

7.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

8.  Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873.

Authors:  Y Saino; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

9.  Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.

Authors:  Y Saino; F Kobayashi; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

10.  Susceptibility to beta-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 beta-lactamases.

Authors:  M Akova; G Bonfiglio; D M Livermore
Journal:  J Med Microbiol       Date:  1991-10       Impact factor: 2.472

View more
  20 in total

1.  Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

Authors:  M B Avison; C S Higgins; C J von Heldreich; P M Bennett; T R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

Authors:  L Zhang; X Z Li; K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Extended spectrum beta-lactamase reactions in Stenotrophomonas maltophilia.

Authors:  J Blahová; M Hupková-Lesická; K Králiková; V Krcméry
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

Review 4.  Carbapenem-hydrolyzing beta-lactamases.

Authors:  B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds.

Authors:  Y Arakawa; N Shibata; K Shibayama; H Kurokawa; T Yagi; H Fujiwara; M Goto
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.

Authors:  S Bellais; D Aubert; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 7.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 8.  Carbapenemase-producing Enterobacteriaceae in animals and methodologies for their detection.

Authors:  Rebecca E V Anderson; Patrick Boerlin
Journal:  Can J Vet Res       Date:  2020-01       Impact factor: 1.310

Review 9.  Meropenem clinical pharmacokinetics.

Authors:  J W Mouton; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

10.  Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.

Authors:  P Hejnar; M Kolár; Z Chmela
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.